JPS62262998A - Production of material containing lysophospholipid essentially free from residual enzymatic activity - Google Patents
Production of material containing lysophospholipid essentially free from residual enzymatic activityInfo
- Publication number
- JPS62262998A JPS62262998A JP10632986A JP10632986A JPS62262998A JP S62262998 A JPS62262998 A JP S62262998A JP 10632986 A JP10632986 A JP 10632986A JP 10632986 A JP10632986 A JP 10632986A JP S62262998 A JPS62262998 A JP S62262998A
- Authority
- JP
- Japan
- Prior art keywords
- lysophospholipid
- phospholipase
- residual
- phospholipid
- containing material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 230000002255 enzymatic effect Effects 0.000 title abstract description 12
- 230000000694 effects Effects 0.000 claims abstract description 28
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 24
- 102100037611 Lysophospholipase Human genes 0.000 claims abstract description 21
- 108010058864 Phospholipases A2 Proteins 0.000 claims abstract description 21
- 239000000126 substance Substances 0.000 claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 15
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 229940042880 natural phospholipid Drugs 0.000 claims abstract description 8
- 239000002798 polar solvent Substances 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 7
- 238000001694 spray drying Methods 0.000 claims abstract description 6
- 102000004190 Enzymes Human genes 0.000 claims description 34
- 108090000790 Enzymes Proteins 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000006911 enzymatic reaction Methods 0.000 abstract description 19
- 239000012467 final product Substances 0.000 abstract description 15
- 150000002632 lipids Chemical class 0.000 abstract description 10
- 239000000843 powder Substances 0.000 abstract description 10
- 241001465754 Metazoa Species 0.000 abstract description 7
- 239000002904 solvent Substances 0.000 abstract description 7
- 210000002969 egg yolk Anatomy 0.000 abstract description 6
- 230000007935 neutral effect Effects 0.000 abstract description 5
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 210000000496 pancreas Anatomy 0.000 abstract description 4
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 30
- 238000000034 method Methods 0.000 description 21
- 239000000047 product Substances 0.000 description 21
- 239000007795 chemical reaction product Substances 0.000 description 16
- 238000000638 solvent extraction Methods 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 238000000605 extraction Methods 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 235000013345 egg yolk Nutrition 0.000 description 8
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 6
- 102000002322 Egg Proteins Human genes 0.000 description 6
- 108010000912 Egg Proteins Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 102000015439 Phospholipases Human genes 0.000 description 4
- 108010064785 Phospholipases Proteins 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000013505 freshwater Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 3
- CWRILEGKIAOYKP-SSDOTTSWSA-M [(2r)-3-acetyloxy-2-hydroxypropyl] 2-aminoethyl phosphate Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCCN CWRILEGKIAOYKP-SSDOTTSWSA-M 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000000991 chicken egg Anatomy 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- ZPDQFUYPBVXUKS-YADHBBJMSA-N 1-stearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OC[C@H](N)C(O)=O ZPDQFUYPBVXUKS-YADHBBJMSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940079919 digestives enzyme preparation Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- UOXRPRZMAROFPH-IESLQMLBSA-N lysophosphatidylinositol Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OC1[C@H](O)[C@@H](O)C(O)[C@@H](O)[C@H]1O UOXRPRZMAROFPH-IESLQMLBSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000003998 snake venom Substances 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- 150000001784 cerebrosides Chemical class 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000008344 egg yolk phospholipid Substances 0.000 description 1
- 229940068998 egg yolk phospholipid Drugs 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- -1 etc. Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- AHAREKHAZNPPMI-UHFFFAOYSA-N hexa-1,3-diene Chemical compound CCC=CC=C AHAREKHAZNPPMI-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は実質的に残存酵素活性を有さないリゾリン脂質
含有物の製造法に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a method for producing a lysophospholipid-containing product having substantially no residual enzymatic activity.
リゾリン脂質はリン脂質から脂肪酸が一つ切断されて水
ME1により置換されたものなので、リン脂質より親水
性が高く、よってこのものよりpHや温度変化に対して
より安定なエマルジョンを形成しつる天然の強力な界面
活性剤である。このためにリゾリン脂質は食品、化粧品
、医薬品等の分野においてリン脂質よりその応用範囲が
広いとされている。Lysophospholipids are phospholipids in which one fatty acid is cleaved and replaced with water ME1, so they are more hydrophilic than phospholipids, and therefore form emulsions that are more stable against changes in pH and temperature than phospholipids. is a strong surfactant. For this reason, lysophospholipids are said to have a wider range of applications than phospholipids in the fields of foods, cosmetics, pharmaceuticals, and the like.
リゾリン脂質は従来天然のリン脂質含有物質から製造さ
れている。例えば、特開昭55−315号公報が開示し
ている「天然型リゾレシチンの新規な製造法」を代表的
な方法として挙げることができる。この従来法によれば
、レシチン含有旦の多い動植物組織ホモジネートにパン
クレアチンを作用させ、反応後加熱処理して蛋白質を熱
変性させたのちン濾過により分別した凝固蛋白質からそ
れに吸着しているリゾレシチンを一連の有機溶媒抽出等
の手段により分離し、次いでこの有機溶媒抽出の場合に
は抽出液から使用溶媒を留去して目的とする天然性リゾ
レシチンを得ている。Lysophospholipids are conventionally produced from natural phospholipid-containing materials. For example, ``Novel method for producing natural lysolecithin'' disclosed in Japanese Patent Application Laid-Open No. 55-315 can be cited as a representative method. According to this conventional method, pancreatin is applied to animal and plant tissue homogenates that contain a large amount of lecithin, and after the reaction, the proteins are heat-denatured by heat treatment, and the lysolecithin adsorbed therein is separated from the coagulated proteins by filtration. The target natural lysolecithin is obtained by separating by a series of methods such as organic solvent extraction, and then, in the case of organic solvent extraction, the solvent used is distilled off from the extract.
しかしこうして得られたリゾレシチンにはバンクレアチ
ンの一構成酵素であるホスホリパーゼA2のM素話性が
残存しているのが認められている。ホスホリパーゼA2
は分子内に多数のジスルフィド結合を含み、そのために
加熱や有機溶媒等に対して極めてnい安定性を示し、こ
れらによっては容易に失活しないことが知られている(
Biochim、 Biophys、 Acta、、第
159巻、第113頁、1968年参照)。それ故、ホ
スホリパーゼA2の酵素活性が残存しているリゾレシチ
ンは、食品、化粧品、医薬品等のg!J造に用いた際例
えばその基質であるリン脂質が存在するなどするとp
l−1が4以下の場合を除いてこのリン脂質を加水分解
して新たに脂肪酸を生成してしまうなど、製品の安定性
を低下させてしまいその商品価値を著しく損ねるように
なる。よって、このようなリゾレシチンの使用は制限さ
れてしまう。However, it has been observed that the lysolecithin thus obtained retains the M speech properties of phospholipase A2, which is a constituent enzyme of vancreatin. Phospholipase A2
It is known that it contains many disulfide bonds in its molecule, and therefore exhibits extremely low stability against heat, organic solvents, etc., and is not easily deactivated by these agents (
Biochim, Biophys, Acta, vol. 159, p. 113, 1968). Therefore, lysolecithin in which the enzyme activity of phospholipase A2 remains is used in foods, cosmetics, pharmaceuticals, etc. When used for J construction, for example, if phospholipids, which are the substrate, are present, p
Unless l-1 is 4 or less, this phospholipid is hydrolyzed to generate new fatty acids, which reduces the stability of the product and significantly reduces its commercial value. Therefore, the use of such lysolecithin is limited.
ホスホリパーゼA2の残存酵素活性を実質的に有ざない
リプリン脂質含有物を得るために、その製造工程ににお
いて各種の溶剤を用いた溶剤分別、シリカゲル等を用い
たカラム処理等を組合わせて実施することによりある程
度の目的達成は期持し得ても、その操作には時間や費用
がかかりすぎ、しかも収率も低下するなど種々の問題点
が認められる。In order to obtain a lipulin lipid-containing product that has substantially no residual enzyme activity of phospholipase A2, the manufacturing process is carried out in combination with solvent fractionation using various solvents, column treatment using silica gel, etc. Although the objective can be achieved to some extent, various problems are recognized, such as the operation takes too much time and cost, and the yield also decreases.
このような現状にあって、本発明は、実質的に残存酵素
活性を有さないリゾリン脂質含有物を工業的規模で容易
にしかも高い収率で製造しつる方法を提供することを目
的とする。Under these circumstances, an object of the present invention is to provide a method for easily producing a lysophospholipid-containing material having substantially no residual enzymatic activity on an industrial scale and at a high yield. .
(問題点を解決するための手段)
本発明者は上記の目的に即して鋭意研究を重ねた結果、
天然のリン脂質含有物質を酵素反応に付した後、一旦そ
の水分含量が10%以下になるまで乾燥させるならば次
いで極性溶媒を用いて溶媒抽出したのち使用溶媒を除去
するだけで容易に残存酵素活性を実質的に有さないリゾ
リン脂質含有物を従来より一段と高い収率で製造するこ
とができることを見出し、本発明を完成するに至った。(Means for solving the problem) As a result of extensive research in accordance with the above purpose, the present inventor has found that
After subjecting a natural phospholipid-containing substance to an enzymatic reaction, if it is dried until its moisture content is 10% or less, residual enzymes can be easily removed by solvent extraction using a polar solvent and removal of the used solvent. The present inventors have discovered that a lysophospholipid-containing material having substantially no activity can be produced in a much higher yield than conventional methods, and have completed the present invention.
本発明は、天然のリン脂質含有物質にホスホリパーゼA
2製剤あるいはホスホリパーゼへ2を含む酵素製剤を作
用させて上記含有物質中のリン脂質を分解してリゾリン
脂質にした後、この物質の水分含量が10%以下になる
まで乾燥させ、次いで極性溶媒を用いてこの物質からリ
ゾリン脂質を抽出し、この抽出液から上記極性溶媒を留
去することを特徴とする、実質的に残存酵素活性を有さ
ないリゾリン脂質含有物の製造法を提供するものである
。The present invention provides phospholipase A to natural phospholipid-containing substances.
2 preparation or an enzyme preparation containing 2 is applied to phospholipase to decompose the phospholipids in the above-mentioned substances into lysophospholipids, and then this substance is dried until the water content becomes 10% or less, and then the polar solvent is removed. The present invention provides a method for producing a lysophospholipid-containing product having substantially no residual enzymatic activity, the method comprising extracting lysophospholipids from this substance using be.
本発明の方法において使用する天然のリン脂質含有物質
は動物、植物、微生物など生体由来のリン脂質を含む物
質であって、具体的には、リン脂質が多く含まれている
動植物組織あるいは微生物菌体、例えば鶏卵黄、牛脳、
豚脳、大豆、菜種、クロレラ細胞、糸状菌菌体(クスダ
マカビ属菌菌体など);およびこれら動植物組織あるい
は微生物菌体から抽出した粗リン脂質抽出物、例えば市
販大豆リン脂質(通常リン脂質含ff160%以上)、
市販卵黄リン脂質(通常リン脂質含量30%以上)、等
を挙げることができる。尚、使用に際して、例えば動植
物組織、微生物図体などを用いるときは酵素作用を効果
的に行なわせるためにこれらは破砕状物あるいは液状物
にして用いるとよい。The natural phospholipid-containing substances used in the method of the present invention are substances containing phospholipids derived from living organisms such as animals, plants, and microorganisms. body, such as chicken egg yolk, cow brain,
Pig brain, soybean, rapeseed, chlorella cells, filamentous fungal cells (such as A. fungus cells); and crude phospholipid extracts extracted from these animal and plant tissues or microbial cells, such as commercially available soybean phospholipids (usually containing phospholipids). ff160% or more),
Examples include commercially available egg yolk phospholipids (usually phospholipid content of 30% or more). In addition, when using, for example, animal and plant tissues, microorganism bodies, etc., it is preferable to use these in crushed or liquid form in order to effectively carry out the enzyme action.
本発明の方法によれば、上記したような天然のリン脂質
含有物質にまず、ホスホリパーゼA2製剤あるいはホス
ホリパーゼA2を含む酵素製剤を作用させ該物質中のリ
ン脂質を分解してリゾリン脂質にする。ここにおいて、
ホスホリパーゼA2製剤あるいはホスホリパーゼA2を
含む酵素製剤としては、例えば動物の膵臓から抽出した
酵素の混合物、即ちバンクレアチン;バンクレアチンを
熱処理に付してプロテアーゼ、リパーゼを失活させてホ
スホリパーゼA2を富化させたもの(特開昭59−第8
8040号公報参照);動物膵臓由来の精製ホスホリパ
ーゼA2製剤:蛇毒、フ1チ毒由来のホスホリパーゼA
21J剤等を用いればよい。According to the method of the present invention, a phospholipid-containing substance as described above is first treated with a phospholipase A2 preparation or an enzyme preparation containing phospholipase A2 to decompose the phospholipid in the substance into lysophospholipid. put it here,
Phospholipase A2 preparations or enzyme preparations containing phospholipase A2 include, for example, a mixture of enzymes extracted from animal pancreas, namely vancreatin; vancreatin is subjected to heat treatment to inactivate protease and lipase to enrich phospholipase A2. (Japanese Unexamined Patent Publication No. 1983-8)
(Refer to Publication No. 8040); Purified phospholipase A2 preparation derived from animal pancreas: Phospholipase A derived from snake venom and venom
21J agent or the like may be used.
これらの市販品が好ましく用いられる。These commercially available products are preferably used.
これらの酵素製剤を用いた酵素反応は、常法に従って実
施に際して適宜決定した条件下で行えばよく、本発明に
おいて特に限定的でない。尚、リゾリン脂質への変換率
を高めるには酵素による分解時間を長くすればよい。Enzyme reactions using these enzyme preparations may be carried out under appropriately determined conditions according to conventional methods, and are not particularly limited in the present invention. Incidentally, in order to increase the conversion rate to lysophospholipids, the decomposition time by the enzyme may be lengthened.
本発明の方法によれば、酵素反応によって得られた反応
生成物は次いでその水分含量を10%以下になるまで乾
燥する。この水分含mを10%以下とすることは本発明
の方法の臨界的な条件である。後述の試験例1の結果か
ら明らかなように水分含aが10%を超えると次の溶媒
抽出工程において使用酵素の一部が抽出液中に移行され
易くなり、よってホスホリパーゼA2の酵素活性が残存
している最終製品が得られるようになるからである。According to the method of the present invention, the reaction product obtained by the enzymatic reaction is then dried until its water content is reduced to 10% or less. Setting the water content m to 10% or less is a critical condition for the method of the present invention. As is clear from the results of Test Example 1 described later, when the water content a exceeds 10%, a part of the enzyme used is likely to be transferred into the extract in the next solvent extraction step, so that the enzymatic activity of phospholipase A2 remains. This is because you will be able to get the final product that you are looking for.
この際、乾燥手段は特に限定的でなく、従来のいかなる
乾燥手段も利用しうる。但し、乾燥の際反応生成物に熱
をかけ過ぎて加熱変性を生じさせないようにこのものの
温度が80℃以上にならないようにすべきである。噴霧
乾燥、凍結乾燥等の手段を採用すると反応生成物自体の
温度は高々60℃程度にしかならないのでこの中に存在
する蛋白質が全く、またはほとんど加熱変性を受けず、
それ故後述の試験例2の結果から明らかなように次の溶
媒抽出工程においてリゾリン脂質の抽出効率がよく、延
いては最終製品の収率を高めうる。At this time, the drying means is not particularly limited, and any conventional drying means may be used. However, the temperature of the reaction product should not exceed 80° C. during drying so as not to overheat the reaction product and cause thermal denaturation. When methods such as spray drying and freeze drying are used, the temperature of the reaction product itself is only about 60°C, so the proteins present therein are not denatured by heat at all or hardly.
Therefore, as is clear from the results of Test Example 2 described below, the extraction efficiency of lysophospholipids is good in the next solvent extraction step, and the yield of the final product can be increased.
尚、水分含量が10%以下にまで乾燥された反応生成物
は通常粉末状になっている。Note that the reaction product dried to a moisture content of 10% or less is usually in the form of a powder.
本発明の方法によれば、上記のようにして得られた粉末
状物は次いで極性溶媒による溶媒抽出に付し、この物質
からリゾリン脂質を抽出する。この際極性溶媒としては
、特に限定的でないが、エタノール、メタノール、クロ
ロホルム−メタノール混合液、酢酸エチルなどが用いら
れ、特にエタノールおよびメタノールが好ましく用いら
れる。According to the method of the invention, the powder obtained as described above is then subjected to solvent extraction with a polar solvent to extract lysophospholipids from this material. In this case, the polar solvent used is, but not particularly limited to, ethanol, methanol, a chloroform-methanol mixture, ethyl acetate, etc., and ethanol and methanol are particularly preferably used.
尚、ヘキサジ、アセトン等の非極性溶媒ではリゾリン脂
質に対する抽出力が小さく、よって本発明においては好
ましくない。また、溶媒抽出は常法に従って実施すれば
よく特に限定的でない。Note that non-polar solvents such as hexadiene and acetone have low extraction power for lysophospholipids, and are therefore not preferred in the present invention. Further, solvent extraction may be carried out according to a conventional method and is not particularly limited.
本発明の方法によれば、こうして1qられた抽出液から
用いた溶媒を、例えば減圧下で留去ずれば、実質的に残
存酵素活性を有さないリゾリン脂質含有物が得られる。According to the method of the present invention, by distilling off the solvent used from the extract obtained in this way under reduced pressure, for example, a lysophospholipid-containing material having substantially no residual enzyme activity can be obtained.
この最終製品は、出発原料中のリン脂質が一般的には1
0〜100%の変換率でリゾリン脂質に換えられたもの
で、そのリゾリン脂質としては、組成的に通常リゾホス
ファチジルコリン(LPG) 、リゾホスファチジルエ
タノールアミン(LPE)、リゾホスファチジン酸(L
PA)、リゾホスファチジルイノシトール(LPり、リ
ゾホスファチジルセリン(LPS)等を含むものである
。よって、この最終製品の全組成は、具体的には、例え
ば中性脂質68%、リン脂質32%(このうちリゾ型は
30%)から成るようなものである。リゾリン脂質の最
終製品中で占める割合が10%未満であるとこのものを
食品、化粧品、医薬品等の分野で用いた際リゾリン脂質
の特性が生かされた製品が得難くなる。また、この最終
製品は実質的に残存酵素活性を有さないものであるが、
ここにおいて「実質的に残存酵素活性を有さない」とは
、残存ホスホリパーゼA2の酵素活性が最終製品1g当
りo、11u以下であることを意味する。但し、11U
(1国際型位)は1分間に1μmolの脂肪酸を基質
からT1離する酵素活性の邑を示す。残存酵素活性が0
.11U/gを超すと、このものを原料として他の製品
に配合したとき保存中に酵素反応が進んで遊離脂肪酸が
生成するなどしてその製品の変質を1Gいてしまう。This final product has a phospholipid content of 1% in the starting material.
It is converted into lysophospholipids at a conversion rate of 0 to 100%, and the lysophospholipids usually include lysophosphatidylcholine (LPG), lysophosphatidylethanolamine (LPE), and lysophosphatidic acid (L).
PA), lysophosphatidylinositol (LP), lysophosphatidylserine (LPS), etc. Therefore, the total composition of this final product is, for example, 68% neutral lipids and 32% phospholipids (of which If the proportion of lysophospholipids in the final product is less than 10%, the properties of lysophospholipids will deteriorate when used in the fields of food, cosmetics, pharmaceuticals, etc. This makes it difficult to obtain a product that retains its enzyme activity.Also, although this final product has virtually no residual enzyme activity,
Here, "having substantially no residual enzymatic activity" means that the enzymatic activity of residual phospholipase A2 is 0.11 u or less per 1 g of the final product. However, 11U
(1 international type position) indicates the level of enzyme activity that separates 1 μmol of fatty acid from the substrate T1 per minute. Residual enzyme activity is 0
.. If it exceeds 11 U/g, when this product is blended into other products as a raw material, enzymatic reactions will proceed during storage and free fatty acids will be produced, resulting in 1G of deterioration of the product.
本発明の方法によって得られたリゾリン脂質含有物は上
記したように実質的に残存酵素活性を有さないものであ
るので、従来のリン脂質は熱論、従来のリゾリン脂質含
有物に比べて、例えば界面活性剤として使用した場合高
温でも、また広いDH域でも安定なエマルジョンを形成
し得るばかりか、食品、化粧品、医薬品等の製造に用い
た際これら製品の保存安定性を向上させることができ、
よってこれら分野において従来のリン脂質またはリゾリ
ン脂質S貨物では原料となり得ないとされていた製品の
開発も期待できるものである。Since the lysophospholipid-containing material obtained by the method of the present invention has substantially no residual enzymatic activity as described above, conventional phospholipids have thermal properties, such as When used as a surfactant, it can form stable emulsions even at high temperatures and in a wide DH range, and when used in the production of foods, cosmetics, pharmaceuticals, etc., it can improve the storage stability of these products.
Therefore, in these fields, we can expect the development of products for which conventional phospholipids or lysophospholipid S cargoes could not be used as raw materials.
従来のリゾリン脂質含有物の!FJ造法、典型的には前
)ホした特開昭55−315号公報で間示せる方法、に
比し、本発明の方法において天然のリン脂質含有物質を
酵素反応に付した後リゾリン脂質を溶媒抽出するに先立
ち、従来行なわれていたように酵素反応生成物を加熱処
理’& tfi過するに代えてこの酵素反応生成物を水
分含量が10%以下になるまで乾燥させることにより何
故上記したように実質的に残存酵素活性を有さないリゾ
リン脂質含有物が得られるのかその理由は定かでないが
、多分、従来の方法におけるように濾過しただけの凝固
蛋白質中には後述の試験例の結果より明らかなように通
常約28%程度もの水分がまだ保存されているためか、
次いで’FJ媒抽出に付した際加熱処理しても失活して
ない使用酵素の一部が水の存在により形成されているリ
ゾリン脂質のミセル中に取り込まれ、そのまま抽出液中
に移行してしまうのに対し、本発明の方法によれば、酵
素反応生成物は全くあるいはほとんど熱変性を受けずに
その水分含量が10%以下にされているために抽出に際
して使用酵素が抽出液に移行し難く、よって実質的に残
存M前活性を有さないリゾリン脂質含有物が高収率で得
られるのではないかと推定される。Conventional lysophospholipid-containing products! Compared to the FJ manufacturing method, typically the method shown in Japanese Patent Application Laid-Open No. 55-315, the method of the present invention involves subjecting a natural phospholipid-containing substance to an enzymatic reaction and then producing lysophospholipids. Prior to solvent extraction, instead of subjecting the enzymatic reaction product to heat treatment and filtration as conventionally done, the enzymatic reaction product was dried until the water content was 10% or less. Although it is not clear why a lysophospholipid-containing substance with virtually no residual enzymatic activity can be obtained, it is likely that the results of the test examples described below are present in coagulated proteins that have been simply filtered as in the conventional method. As is clearer, this is probably because about 28% of the water is still preserved.
Then, when subjected to 'FJ medium extraction, a part of the enzyme used, which was not inactivated even after heat treatment, was incorporated into the lysophospholipid micelles formed by the presence of water, and transferred directly into the extract solution. In contrast, according to the method of the present invention, the enzyme reaction product undergoes no or almost no thermal denaturation and its water content is reduced to 10% or less, so that the enzyme used during extraction is transferred to the extract solution. Therefore, it is presumed that a lysophospholipid-containing product having substantially no residual pre-M activity can be obtained in high yield.
本発明の効果を以下の試験例1および2の結果でもって
説明する。尚、本発明において%はすぺで重量%である
。The effects of the present invention will be explained with the results of Test Examples 1 and 2 below. In the present invention, all percentages are percentages by weight.
試験例1
この試験例は、本発明の方法において酵素反応生成物の
水分含量を10%以下とすることにより得られる最終製
品が如何に残存酵素活性を実質的に有さないものである
かを示す。Test Example 1 This test example shows how the final product obtained by reducing the water content of the enzyme reaction product to 10% or less in the method of the present invention has substantially no residual enzyme activity. show.
鶏卵黄10(1gにバンクレアチン(和光純’am>5
K9を清水10ρに溶解した液を加え、1N水酸化ナ
トリウム水溶液でp +−+を7.0〜8.0に保ちつ
つ撹拌しながら35〜45℃で6時間酵素反応を行なっ
た。得られた酵素反応生成物をそのまま噴霧乾燥に処し
く吸気温度=130〜150℃。10 chicken egg yolks (1g with bank creatin (Wako Jun'am>5
A solution of K9 dissolved in 10 ρ of fresh water was added, and an enzymatic reaction was carried out at 35 to 45° C. for 6 hours while stirring and maintaining p +−+ at 7.0 to 8.0 with a 1N aqueous sodium hydroxide solution. The obtained enzymatic reaction product was directly subjected to spray drying at an intake air temperature of 130 to 150°C.
排気温度:50〜75℃、反応生成物自体の温度:50
〜60°C) 、水分含m 4 、8 %(D乾燥1n
l黄42Kgを得た。Exhaust temperature: 50-75℃, temperature of reaction product itself: 50
~60°C), moisture content m4, 8% (D dry 1n
42 kg of yellow was obtained.
次いで、こうして得られた乾燥卵黄を用意した2p容ビ
ーカーに各1009ずつ取り、それぞれ加湿操作を行な
った後1日間放置して全体を均一化し、水分含量が4.
8%、9.1%、13.6%および21.0%の粉末状
物を得た。Next, 1,009 pieces of each of the dried egg yolks obtained in this manner were placed in a prepared 2p beaker, and after performing a humidifying operation, they were left to stand for one day to homogenize the whole, and the water content was 4.
8%, 9.1%, 13.6% and 21.0% powders were obtained.
上記水分含かの粉末状物を収容しているご一カー中にそ
れぞれエタノール1fJを加えて40〜45℃で10分
間撹拌下抽出操作を行なった後と濾過して得られた抽出
液を真空濃縮に処し、いずれも黄色ペースト状のリゾリ
ン脂質含有物を得た。Add 1 fJ of ethanol to each car containing the above-mentioned water-containing powder, perform an extraction operation with stirring at 40-45°C for 10 minutes, and then filter the resulting extract under vacuum. After concentration, yellow paste-like lysophospholipid-containing products were obtained.
次いで各含有物を収率および残存酵素活性について調べ
た。その結果を下記の表1に示す。尚、水分含量はケラ
ト式水分計を用いて測定しく温度105℃)、またホス
ホリパーゼA2の残存酵素活性の測定はBiochim
、 Biophys、 ACta、 。Each content was then tested for yield and residual enzyme activity. The results are shown in Table 1 below. The water content was measured using a Kerato moisture meter (temperature: 105°C), and the residual enzyme activity of phospholipase A2 was measured using Biochim.
, Biophys, ACta, .
第159巻、第105頁(1968年)に記載されてい
る方法に準じて行なった。This was carried out according to the method described in Vol. 159, p. 105 (1968).
表 1
上記表1の結果より、水分含量が10%以下では残存酵
素活性が認め難いのに対して、10%を超えると残存酵
素活性がかなり認められるようになることがわかる。Table 1 From the results in Table 1 above, it can be seen that residual enzyme activity is difficult to recognize when the water content is 10% or less, whereas residual enzyme activity is considerably recognized when the water content exceeds 10%.
試験例2
この試験例は、酵素反応後の操作において従来法(特開
昭55−315号公報で開示せる方法)による酵素反応
生成物の加熱処理後ン濾過という操作に代えて本発明の
方法により該生成物を水分含量10%以下まで乾燥させ
ることにより如何に最終製品が収率および残存酵素活性
の点で有利に得られるかを示す。Test Example 2 In this test example, the method of the present invention was used in place of the conventional method (method disclosed in JP-A No. 55-315) in which the enzymatic reaction product was heated and then filtered. shows how the final product can be advantageously obtained in terms of yield and residual enzyme activity by drying the product to a moisture content of less than 10%.
上記の試験例1の方法に準じて得られた酵素反応後の卵
黄液2 KWを95〜100℃にて1時間加熱変性処理
した後加圧濾過で脱水し、水分含量28.0%の固形物
(A)1194gを得た。この際加圧か過ではこれ以上
水分台mを減らすことはできなかった。Egg yolk liquid 2 KW obtained after the enzymatic reaction obtained according to the method of Test Example 1 above was heat denatured at 95 to 100°C for 1 hour, and then dehydrated by pressure filtration to form a solid with a water content of 28.0%. 1194 g of product (A) was obtained. At this time, it was not possible to further reduce the moisture level m by pressurizing or overpressuring.
こうして得られた固形物(A>のうち500gを凍結乾
燥に処して水分含量1.6%の乾燥物(B)365gを
(りた。500 g of the solid material (A) thus obtained was freeze-dried to yield 365 g of a dried material (B) with a moisture content of 1.6%.
他方、上記試験例1の方法に準じて得られた酵素反応後
の卵黄液2 Kgを加熱変性処理せずにそのまま噴霧乾
燥に処しく吸気温度:130〜150℃、排気温度=5
0〜75℃、反応生成物自体の温度=50〜60℃)、
水分含量4.3%の粉末(C)840gを得た。On the other hand, 2 kg of the enzymatically reacted egg yolk liquid obtained according to the method of Test Example 1 above was subjected to spray drying without being subjected to heat denaturation treatment. Intake temperature: 130 to 150°C, exhaust temperature = 5
0-75°C, temperature of the reaction product itself = 50-60°C),
840 g of powder (C) with a moisture content of 4.3% was obtained.
このようにして得られた1llA、BおよびC各200
9に次いでそれぞれエタノール21を加えて40〜45
℃で10分間撹拌下抽出操作を行なった後濾過して得ら
れた抽出液を貞空濃縮に処し、いずれも黄色ペースト状
のリゾリン脂質含有物を得た。Thus obtained 1llA, B and C each 200
9 and then add 21 ethanol to 40 to 45
After performing an extraction operation under stirring at .degree. C. for 10 minutes, the resulting extract was filtered and subjected to vacuum concentration to obtain a yellow paste-like lysophospholipid-containing material.
次いで各含有物を収率および残存酵素活性について調べ
た。その結果を下記の表2に示す。Each content was then tested for yield and residual enzyme activity. The results are shown in Table 2 below.
表 2
上記表2の結果より、Aは水分含量が多いためか溶媒抽
出の際使用酵素の一部が抽出液中に移行するためにかな
り残存酵素活性の認められる最終製品が得られ、しかも
リゾリン脂質以外に蛋白質等も抽出されてしまうために
見掛は上の収率は高く、またBは水分含量は少ないので
ほとんど残存酵素活性が認められない最終製品は1qら
れても加熱変性を受けているために溶媒抽出に際してリ
ゾリン脂質が抽出され難く、よって最終製品の収率がか
なり低く、−万Cはほとんど加熱変性を受けないために
溶媒抽出工程においてリゾリン脂質の抽出効率がよく、
それ故最終製品の収率も高く、しかも残存酵素活性が認
め難いものであることがわかる。Table 2 From the results in Table 2 above, it can be seen that A has a high water content, and a portion of the enzyme used during solvent extraction migrates into the extract, resulting in a final product with considerable residual enzyme activity. The apparent yield is high because proteins, etc. are extracted in addition to lipids, and since B has a low water content, the final product has almost no residual enzyme activity. Because of this, lysophospholipids are difficult to extract during solvent extraction, and the yield of the final product is quite low.
Therefore, it can be seen that the yield of the final product is high and that residual enzyme activity is hardly noticeable.
以下、本発明を実施例でもって更に詳しく説明する。 Hereinafter, the present invention will be explained in more detail with reference to Examples.
実施例1
鶏卵黄100 Kgにバンクレアチン(和光紬薬製)5
に3を清水101に溶解した液を加え、1N水酸化ナト
リウム水溶液でpHを7.0〜8.0に保らつつ撹拌し
ながら35〜45℃で6時間酵素反応を行なった。得ら
れた酵素反応生成物をそのまま噴霧乾燥に処しく吸気温
度=130〜150℃、排気温度=50〜75℃、反応
生成物自体の温度:50〜60℃〉、水分含量5.2%
の乾燥卵黄42.5Kgを得た。Example 1 100 kg of chicken egg yolk and 5 pieces of bank creatin (manufactured by Wako Tsumugi Pharmaceutical Co., Ltd.)
A solution prepared by dissolving 3 in 101 fresh water was added to the solution, and the enzyme reaction was carried out at 35 to 45° C. for 6 hours while stirring and maintaining the pH at 7.0 to 8.0 with a 1N aqueous sodium hydroxide solution. The obtained enzymatic reaction product was directly subjected to spray drying; intake air temperature = 130-150°C, exhaust temperature = 50-75°C, temperature of the reaction product itself: 50-60°C>, moisture content 5.2%.
42.5 kg of dried egg yolk was obtained.
この乾燥卵黄にエタノール400gを加えて40〜45
℃で10分間撹拌下抽出操作を行なった110濾過して
得られた抽出液を真空濃縮に処しく品温30℃以下)、
黄色ペースト状リゾリン脂質含有物19.5Ny(収率
19.5%)を得た。Add 400g of ethanol to this dried egg yolk and add 40 to 45
The extract obtained by 110 filtration was subjected to an extraction operation under stirring for 10 minutes at 110 °C and was then concentrated in vacuum (with a product temperature of 30 °C or less).
A yellow paste-like lysophospholipid-containing material of 19.5 Ny (yield: 19.5%) was obtained.
次いでこの含有物の脂質組成をイヤトロスキ1?ンTH
IO(filヤトロン社製)を用いて下記の測定条件の
下で調べたところ、中性脂質(主にトリグリセリド、コ
レステロール)67.9%およびリン脂質32.1%(
このうらLPCおよびLPEは30.6%)であった。Next, the lipid composition of this inclusion was determined by Iatroski1? NTH
When investigated using IO (manufactured by Fil Yatron) under the following measurement conditions, 67.9% of neutral lipids (mainly triglycerides and cholesterol) and 32.1% of phospholipids (
Behind this, LPC and LPE were 30.6%).
測定条件
ロ ツ ド:り0マOツド5−II(シリカゲル)g1
g1溶剤:クロロホルム:メタノール:水80
:35 :3
(V/V/V )
展開距11:10crR
更に最終製品を残存酵素活性について調べたところ0.
11U/9以下であった。尚、抽出液を分離した後の残
漬には約201U/gの残存活性が認められた。Measurement conditions Rod: 0 mA 5-II (silica gel) g1
g1 Solvent: Chloroform: Methanol: Water 80
:35 :3 (V/V/V) Development distance 11:10crR Further, the final product was examined for residual enzyme activity and found to be 0.
It was 11U/9 or less. In addition, residual activity of about 201 U/g was observed in the residue after separating the extract.
実施例2
市販の大豆リン脂質製品(リン脂質含ff162%)2
00 Kgに市販の精製ホスホリパーゼA、、!1剤(
初物膵臓由来品: 1001tJ/119>709を清
水31に溶解した液を加え、4N水酸化カルシウム水溶
液でpH8,5に保ちつつ撹拌しながら50〜55℃で
24時間酵素反応を行なった。次いで清水200 Kg
および斌形剤としてテキストリン粉末40Kgを加えて
ホモジナイザーで乳化したのち噴霧乾燥に処しく吸気温
度:150〜170℃、排気温度=50〜75℃、乳化
物自体の温度=60℃)、水分含ff13.8%(7)
粉末228Kgel?た。Example 2 Commercially available soybean phospholipid product (phospholipid content ff162%) 2
00 Kg commercially available purified phospholipase A,,! 1 drug (
A solution derived from primary pancreas: 1001tJ/119>709 dissolved in clear water 31 was added, and an enzymatic reaction was carried out at 50 to 55°C for 24 hours while stirring and maintaining the pH at 8.5 with a 4N aqueous calcium hydroxide solution. Next, 200 kg of fresh water
After adding 40 kg of Textrin powder as a bulking agent and emulsifying it with a homogenizer, it was spray-dried. ff13.8% (7)
Powder 228Kgel? Ta.
この粉末にメタノール2000Mを加えて40〜45℃
で20分間撹拌下抽出操作を行なった後濾過して得られ
た抽出液を真空濃縮に処し、褐色ペースト18ig(収
率91%)を得た。Add 2000M methanol to this powder and
After extraction under stirring for 20 minutes, the resulting extract was filtered and concentrated in vacuo to obtain 18ig of brown paste (yield: 91%).
次いでこのペーストの脂質組成を上記実施例1の場合と
同様にして調べたところ、中性脂質(主にトリグリセリ
ド、ステロール類)22.0%およびリン脂[78,0
%(このうちリゾ型34.2%)であった。Next, the lipid composition of this paste was examined in the same manner as in Example 1, and it was found that neutral lipids (mainly triglycerides and sterols) were 22.0% and phospholipids [78.0%].
% (34.2% of which was Lyso type).
また、残存M素話性は0.11U/9以下であった。Further, the residual M speech property was 0.11 U/9 or less.
衷11ユ
用息した牛脳(破砕状物)150Kgに市販のホスホリ
パーゼA2製剤(蛇毒由来品300IU/9)3(lを
清水51に溶解した液を加え、1N水酸化カルシウム水
溶液でDH8,5に保ちつつ撹拌しながら40〜50℃
で6時間酵素反応を行なった。得られた酵素反応生成物
をそのまま凍結乾燥に処して水分含ff11.4%の乾
燥物68.4に9を得た。A commercially available phospholipase A2 preparation (300 IU/9) of a commercially available phospholipase A2 preparation (snake venom-derived product, 300 IU/9) was dissolved in 51 liters of fresh water, and added to 150 kg of crushed bovine brain that had been breathed with 11 U. 40-50℃ while stirring
The enzymatic reaction was carried out for 6 hours. The obtained enzymatic reaction product was directly freeze-dried to obtain a dry product with a water content of 11.4%, 68.4 to 9.
この乾燥物にエタノール68ONを加えて40〜45℃
で10分間撹拌下抽出操作を行なった後ン濾過して得ら
れた抽出液を真空濃縮に処し、黄色ベースI・状リゾリ
ン脂質含有物10.2/(g(収率6.8%)を得た。Add ethanol 68ON to this dried product and heat at 40-45°C.
After extraction with stirring for 10 minutes, the extract obtained by filtration was concentrated in vacuo to obtain 10.2 g (yield: 6.8%) of a yellow base I-type lysophospholipid-containing substance. Obtained.
次いでこの含有物の脂質組成を上記実施例1の場合と同
様にして調べたところ、中性脂質(主にコレステロール
)20%およびリン脂質46%(このうちリゾ型21%
)および糖脂質(主にセレブロシド)34%であった。Next, the lipid composition of this content was investigated in the same manner as in Example 1, and it was found that 20% of neutral lipids (mainly cholesterol) and 46% of phospholipids (of which 21% were lyso-type).
) and glycolipids (mainly cerebrosides) were 34%.
また、残存酵素活性は0.11U157以下であった。Further, the residual enzyme activity was 0.11U157 or less.
Claims (1)
剤あるいはホスホリパーゼA_2を含む酵素製剤を作用
させて上記含有物質中のリン脂質を分解してリゾリン脂
質にした後、この物質の水分含量が10%以下になるま
で乾燥させ、次いで極性溶媒を用いてこの物質からリゾ
リン脂質を抽出し、この抽出液から上記極性溶媒を留去
することを特徴とする、実質的に残存酵素活性を有さな
いリゾリン脂質含有物の製造法。 2、乾燥は噴霧乾燥あるいは凍結乾燥により行なう、特
許請求の範囲第1項に記載の実質的に残存酵素活性を有
さないリゾリン脂質含有物の製造法。 3、極性溶媒としてエタノールあるいはメタノールを用
いる、特許請求の範囲第1項に記載の実質的に残存酵素
活性を有さないリゾリン脂質含有物の製造法。[Claims] 1. After treating a natural phospholipid-containing substance with a phospholipase A_2 preparation or an enzyme preparation containing phospholipase A_2 to decompose the phospholipid in the above-mentioned substance into lysophospholipid, the water content of this substance is reduced. Drying until the content is 10% or less, then extracting lysophospholipids from this substance using a polar solvent, and distilling off the polar solvent from this extract, substantially eliminating residual enzyme activity. A method for producing a lysophospholipid-containing product. 2. The method for producing a lysophospholipid-containing product having substantially no residual enzyme activity according to claim 1, wherein drying is carried out by spray drying or freeze drying. 3. A method for producing a lysophospholipid-containing material having substantially no residual enzyme activity according to claim 1, which uses ethanol or methanol as a polar solvent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10632986A JPS62262998A (en) | 1986-05-09 | 1986-05-09 | Production of material containing lysophospholipid essentially free from residual enzymatic activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10632986A JPS62262998A (en) | 1986-05-09 | 1986-05-09 | Production of material containing lysophospholipid essentially free from residual enzymatic activity |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62262998A true JPS62262998A (en) | 1987-11-16 |
JPH0211234B2 JPH0211234B2 (en) | 1990-03-13 |
Family
ID=14430862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10632986A Granted JPS62262998A (en) | 1986-05-09 | 1986-05-09 | Production of material containing lysophospholipid essentially free from residual enzymatic activity |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62262998A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0249593A (en) * | 1988-08-11 | 1990-02-19 | Showa Sangyo Co Ltd | Method for producing lysolecithin |
WO1990011823A1 (en) * | 1989-04-13 | 1990-10-18 | Kabushiki Kaisha Yakult Honsha | Surfactant and process for producing the same |
US5082674A (en) * | 1989-09-29 | 1992-01-21 | Thomas J. Lipton Co., Division Of Conopco, Inc. | Food product |
US5378623A (en) * | 1992-06-16 | 1995-01-03 | Sankyo Company, Limited | Phospholipase A1, process for its preparation and the use thereof |
US5591479A (en) * | 1993-12-31 | 1997-01-07 | Institut De Recherche Biologique | Brain phospholipid composition and method of making for an infant formula |
US6773731B2 (en) | 2002-10-18 | 2004-08-10 | James S. Campbell | Liquid egg yolk product comprising lysophospholipoprotein |
WO2005090587A1 (en) * | 2004-03-18 | 2005-09-29 | Nagase Chemtex Corporation | Method of removing enzyme and method of base exchange or hydrolysis of phospholipid using the same |
US7041328B2 (en) * | 1999-06-17 | 2006-05-09 | Kao Corporation | Acid oil-in-water emulsified composition |
JP2009148244A (en) * | 2007-11-29 | 2009-07-09 | Gunma Prefecture | Method for producing lysophosphatidylethanolamine |
USRE43136E1 (en) | 2002-05-30 | 2012-01-24 | Michael Foods Of Delaware, Inc. | Formulation and process to prepare a pre-formed filing unit |
US8834952B2 (en) | 2001-12-21 | 2014-09-16 | Michael Foods, Inc. | Formulated egg product suitable for processing |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5336688B2 (en) * | 2004-12-22 | 2013-11-06 | 長瀬産業株式会社 | Method for producing lysophospholipid |
JP5336687B2 (en) * | 2004-12-22 | 2013-11-06 | 長瀬産業株式会社 | Method for producing phospholipid hydrolyzate |
-
1986
- 1986-05-09 JP JP10632986A patent/JPS62262998A/en active Granted
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0249593A (en) * | 1988-08-11 | 1990-02-19 | Showa Sangyo Co Ltd | Method for producing lysolecithin |
WO1990011823A1 (en) * | 1989-04-13 | 1990-10-18 | Kabushiki Kaisha Yakult Honsha | Surfactant and process for producing the same |
US5152928A (en) * | 1989-04-13 | 1992-10-06 | Kabushiki Kaisha Yakult Honsha | Surfactant and method for producing the same |
US5082674A (en) * | 1989-09-29 | 1992-01-21 | Thomas J. Lipton Co., Division Of Conopco, Inc. | Food product |
TR25502A (en) * | 1989-09-29 | 1993-05-01 | Unilever Nv | PHOSPHOLIPO PROTEIN CONSIDERING COMPONENTS FOR FOODSTUFFS AND ANIMAL FEEDS |
AU640167B2 (en) * | 1989-09-29 | 1993-08-19 | Unilever Plc | Foodstuffs comprising lyso-phospholipoprotein |
US5378623A (en) * | 1992-06-16 | 1995-01-03 | Sankyo Company, Limited | Phospholipase A1, process for its preparation and the use thereof |
US5521080A (en) * | 1992-06-16 | 1996-05-28 | Sankyo Company, Limited | Phospholipase A1, process for its preparation |
US5538874A (en) * | 1992-06-16 | 1996-07-23 | Sankyo Company, Limited | Phospholipase A1, process for its preparation and the use thereof |
US5591479A (en) * | 1993-12-31 | 1997-01-07 | Institut De Recherche Biologique | Brain phospholipid composition and method of making for an infant formula |
US7041328B2 (en) * | 1999-06-17 | 2006-05-09 | Kao Corporation | Acid oil-in-water emulsified composition |
USRE46654E1 (en) | 2001-12-21 | 2018-01-02 | Michael Foods Of Delaware, Inc. | Process to prepare a premium formulated fried egg |
US8834952B2 (en) | 2001-12-21 | 2014-09-16 | Michael Foods, Inc. | Formulated egg product suitable for processing |
USRE43136E1 (en) | 2002-05-30 | 2012-01-24 | Michael Foods Of Delaware, Inc. | Formulation and process to prepare a pre-formed filing unit |
US6773731B2 (en) | 2002-10-18 | 2004-08-10 | James S. Campbell | Liquid egg yolk product comprising lysophospholipoprotein |
US7709238B2 (en) | 2004-03-18 | 2010-05-04 | Nagase Chemtex Corporation | Method for removing enzyme and method of base exchange or hydrolysis of phospholipid using the same |
JP4650746B2 (en) * | 2004-03-18 | 2011-03-16 | ナガセケムテックス株式会社 | Method for removing enzyme and method for base transfer or hydrolysis of phospholipids using the method |
JPWO2005090587A1 (en) * | 2004-03-18 | 2008-02-07 | ナガセケムテックス株式会社 | Method for removing enzyme and method for base transfer or hydrolysis of phospholipids using the method |
WO2005090587A1 (en) * | 2004-03-18 | 2005-09-29 | Nagase Chemtex Corporation | Method of removing enzyme and method of base exchange or hydrolysis of phospholipid using the same |
JP2009148244A (en) * | 2007-11-29 | 2009-07-09 | Gunma Prefecture | Method for producing lysophosphatidylethanolamine |
Also Published As
Publication number | Publication date |
---|---|
JPH0211234B2 (en) | 1990-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69332217T3 (en) | Phospholipase A1, process for its preparation and use | |
Joshi et al. | Modification of lecithin by physical, chemical and enzymatic methods | |
KR101484656B1 (en) | Extraction of highly unsaturated lipids with liquid dimethyl ether | |
JPS62262998A (en) | Production of material containing lysophospholipid essentially free from residual enzymatic activity | |
US8524282B2 (en) | Method for production of highly pure phospholipid, and highly pure sphingomyelin and plasmalogen-type glycerophospholipid produced by the method | |
JP5489439B2 (en) | Method for producing plasmalogen-type phospholipid and sphingolipid | |
JPH0767580A (en) | Preparation of functionally decholesterolized york article | |
US5153125A (en) | Process for producing lysophospholipids-containing phospholipids with reduced neutral lipid content | |
Juneja et al. | Increasing productivity by removing choline in conversion of phosphatidylcholine to phosphatidylserine by phospholipase D | |
JPH0249593A (en) | Method for producing lysolecithin | |
SK10922001A3 (en) | Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition | |
BRPI0509684B1 (en) | enzymatic production of hydrolysed lecithin products | |
JPS63279753A (en) | Production of enzyme-modified lecithin | |
JPS63253092A (en) | Production of lysophospholipid scarcely containing lyso-type phospholipid other than lpc | |
JPS63233750A (en) | Production of treated phospholipid | |
JP2001186898A (en) | Method for producing phosphatidyl serine having polyvalent unsaturated fatty acid residue | |
CN102712666B (en) | Process for production of purified egg-yolk phospholipid composition, and pharmaceutical composition, cosmetic composition or food composition comprising purified egg-yolk phospholipid composition produced by the process | |
US3925158A (en) | Process of manufacturing enzyme preparation rich in lipase | |
EP0384976B1 (en) | Glycerophospholipid composition having enhanced surface-active properties | |
JP6701461B1 (en) | Plasmalogen-containing composition | |
JPH01175943A (en) | Composition for promoting absorption of lipid substance in intestine | |
JPH07222592A (en) | Production of lysophospholipid by phospholipase a1 | |
JP2515839B2 (en) | Phospholipid purification method | |
JPH0499448A (en) | Oil seed-derived protein | |
JP3616700B2 (en) | Egg yolk phospholipid composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |